|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 160 out of 160 for C9orf72

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.095s

Categories

Category: Publication
Type Details Score
Publication
First Author: Piao X
Year: 2022
Journal: Sci Rep
Title: Dual-gRNA approach with limited off-target effect corrects C9ORF72 repeat expansion in vivo.
Volume: 12
Issue: 1
Pages: 5672
Publication
First Author: Jambeau M
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease.
Volume: 119
Issue: 49
Pages: e2123487119
Publication    
First Author: Shi Y
Year: 2019
Journal: JCI Insight
Title: Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons.
Volume: 5
Publication  
First Author: Martier R
Year: 2019
Journal: Mol Ther Nucleic Acids
Title: Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.
Volume: 16
Pages: 26-37
Publication
First Author: Pattamatta A
Year: 2021
Journal: Hum Mol Genet
Title: Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.
Volume: 29
Issue: 24
Pages: 3900-3918
Publication
First Author: Peters OM
Year: 2015
Journal: Neuron
Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Volume: 88
Issue: 5
Pages: 902-909
Publication  
First Author: Ryan S
Year: 2019
Journal: Neurobiol Aging
Title: CRISPR/Cas9 does not facilitate stable expression of long C9orf72 dipeptides in mice.
Volume: 84
Pages: 235.e1-235.e8
Publication  
First Author: Atanasio A
Year: 2016
Journal: Sci Rep
Title: C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice.
Volume: 6
Pages: 23204
Publication
First Author: Schludi MH
Year: 2017
Journal: Acta Neuropathol
Title: Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss.
Volume: 134
Issue: 2
Pages: 241-254
Publication
First Author: Bennett CL
Year: 2023
Journal: Acta Neuropathol Commun
Title: Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity.
Volume: 11
Issue: 1
Pages: 164
Publication
First Author: Farg MA
Year: 2017
Journal: Hum Mol Genet
Title: The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
Volume: 26
Issue: 15
Pages: 2882-2896
Publication
First Author: Zhou Q
Year: 2020
Journal: EMBO Mol Med
Title: Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model.
Volume: 12
Issue: 2
Pages: e10919
Publication
First Author: Hao Z
Year: 2019
Journal: Nat Commun
Title: Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR.
Volume: 10
Issue: 1
Pages: 2906
Publication
First Author: LaClair KD
Year: 2020
Journal: Acta Neuropathol
Title: Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS.
Volume: 140
Issue: 2
Pages: 121-142
Publication
First Author: Rosbash M
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Metformin treatment of the C9orf72 ALS/FTD mouse: Almost too good for words.
Volume: 117
Issue: 33
Pages: 19627-19628
Publication
First Author: Amick J
Year: 2016
Journal: Mol Biol Cell
Title: C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling.
Volume: 27
Issue: 20
Pages: 3040-3051
Publication    
First Author: Celona B
Year: 2017
Journal: Elife
Title: Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106.
Volume: 6
Publication  
First Author: Zhang YJ
Year: 2019
Journal: Science
Title: Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity.
Volume: 363
Issue: 6428
Publication  
First Author: Rodriguez S
Year: 2021
Journal: Sci Transl Med
Title: Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss.
Volume: 13
Issue: 601
Publication
First Author: Yang F
Year: 2023
Journal: J Neurochem
Title: C9orf72 poly-PR helps p53 escape from the ubiquitin-proteasome system and promotes its stability.
Volume: 166
Issue: 2
Pages: 389-402
Publication
First Author: Herranz-Martin S
Year: 2017
Journal: Dis Model Mech
Title: Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits.
Volume: 10
Issue: 7
Pages: 859-868
Publication  
First Author: Fomin V
Year: 2018
Journal: Mol Cell Biol
Title: The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling.
Volume: 38
Issue: 22
Publication      
First Author: Riemslagh FW
Year: 2021
Journal: Dis Model Mech
Title: Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice.
Publication
First Author: Liu Y
Year: 2021
Journal: Nat Commun
Title: Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models.
Volume: 12
Issue: 1
Pages: 847
Publication
First Author: Kandasamy P
Year: 2022
Journal: Nucleic Acids Res
Title: Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS.
Volume: 50
Issue: 10
Pages: 5401-5423
Publication  
First Author: Liu Y
Year: 2022
Journal: Mol Ther Nucleic Acids
Title: Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD.
Volume: 28
Pages: 558-570
Publication  
First Author: Fu X
Year: 2024
Journal: Exp Neurol
Title: DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
Volume: 376
Pages: 114768
Publication
First Author: Castelli LM
Year: 2023
Journal: Sci Transl Med
Title: A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins.
Volume: 15
Issue: 685
Pages: eabo3823
Publication
First Author: Diaz-Garcia S
Year: 2021
Journal: Acta Neuropathol
Title: Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis.
Volume: 142
Issue: 6
Pages: 985-1001
Publication
First Author: Bush JA
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: A blood-brain penetrant RNA-targeted small molecule triggers elimination of r(G(4)C(2))(exp) in c9ALS/FTD via the nuclear RNA exosome.
Volume: 119
Issue: 48
Pages: e2210532119
Publication
First Author: Wang T
Year: 2022
Journal: Cell Death Differ
Title: Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis.
Volume: 29
Issue: 6
Pages: 1187-1198
Publication
First Author: Herdewyn S
Year: 2013
Journal: Neurobiol Aging
Title: Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats.
Volume: 34
Issue: 10
Pages: 2302-3
Publication
First Author: Bento-Abreu A
Year: 2018
Journal: Hum Mol Genet
Title: Elongator subunit 3 (ELP3) modifies ALS through tRNA modification.
Volume: 27
Issue: 7
Pages: 1276-1289
Publication
First Author: Porta S
Year: 2018
Journal: Nat Commun
Title: Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo.
Volume: 9
Issue: 1
Pages: 4220
Publication
First Author: Lu J
Year: 2019
Journal: Nat Neurosci
Title: L3MBTL1 regulates ALS/FTD-associated proteotoxicity and quality control.
Volume: 22
Issue: 6
Pages: 875-886
Publication  
First Author: Tian F
Year: 2016
Journal: Nat Commun
Title: Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging.
Volume: 7
Pages: 13283
Publication
First Author: Gleixner AM
Year: 2022
Journal: Nat Commun
Title: NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.
Volume: 13
Issue: 1
Pages: 3380
Publication
First Author: Lee S
Year: 2016
Journal: Neuron
Title: Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.
Volume: 91
Issue: 1
Pages: 41-55
Publication
First Author: Clayton EL
Year: 2017
Journal: Hum Mol Genet
Title: Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
Volume: 26
Issue: 5
Pages: 873-887
Publication
First Author: Coyne AN
Year: 2017
Journal: Cell Rep
Title: Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.
Volume: 21
Issue: 1
Pages: 110-125
Publication
First Author: Verdone BM
Year: 2022
Journal: Sci Rep
Title: A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes.
Volume: 12
Issue: 1
Pages: 5644
Publication  
First Author: Matamala JM
Year: 2018
Journal: Neurobiol Aging
Title: Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
Volume: 64
Pages: 123-138
Publication
First Author: Luecke IW
Year: 2023
Journal: Gene Ther
Title: Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS.
Volume: 30
Issue: 6
Pages: 528-533
Publication  
First Author: Van Acker ZP
Year: 2019
Journal: Neuroscience
Title: Non-Methylation-Linked Mechanism of REST-Induced Neuroglobin Expression Impacts Mitochondrial Phenotypes in a Mouse Model of Amyotrophic Lateral Sclerosis.
Volume: 412
Pages: 233-247
Publication  
First Author: Imamura K
Year: 2017
Journal: Sci Transl Med
Title: The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Volume: 9
Issue: 391
Publication  
First Author: Shang J
Year: 2017
Journal: Neuroscience
Title: Aberrant distributions of nuclear pore complex proteins in ALS mice and ALS patients.
Volume: 350
Pages: 158-168
Publication
First Author: Bros-Facer V
Year: 2014
Journal: Hum Mol Genet
Title: Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Volume: 23
Issue: 16
Pages: 4187-200
Publication
First Author: McAlpine W
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function.
Volume: 115
Issue: 49
Pages: E11523-E11531
Publication
First Author: Clayton EL
Year: 2018
Journal: Brain
Title: Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
Volume: 141
Issue: 12
Pages: 3428-3442
Publication
First Author: Gandelman M
Year: 2020
Journal: Cell Death Differ
Title: Staufen 1 amplifies proapoptotic activation of the unfolded protein response.
Volume: 27
Issue: 10
Pages: 2942-2951
Publication
First Author: Busch JI
Year: 2016
Journal: Hum Mol Genet
Title: Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
Volume: 25
Issue: 13
Pages: 2681-2697
Publication
First Author: Ajroud-Driss S
Year: 2015
Journal: Biochim Biophys Acta
Title: Sporadic and hereditary amyotrophic lateral sclerosis (ALS).
Volume: 1852
Issue: 4
Pages: 679-84
Publication
First Author: Jensen BK
Year: 2020
Journal: EMBO Mol Med
Title: Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment.
Volume: 12
Issue: 5
Pages: e10722
Publication
First Author: Huang M
Year: 2020
Journal: Acta Neuropathol Commun
Title: Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Volume: 8
Issue: 1
Pages: 163
Publication
First Author: Nicholson AM
Year: 2018
Journal: Acta Neuropathol Commun
Title: Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity.
Volume: 6
Issue: 1
Pages: 42
Publication
First Author: Milani M
Year: 2021
Journal: J Neuroinflammation
Title: Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.
Volume: 18
Issue: 1
Pages: 132
Publication
First Author: Wang SM
Year: 2023
Journal: Autophagy
Title: Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.
Volume: 19
Issue: 1
Pages: 126-151
Publication
First Author: Arredondo C
Year: 2022
Journal: Neuron
Title: Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons.
Volume: 110
Issue: 10
Pages: 1656-1670.e12
Publication
First Author: Gerhard DS
Year: 2004
Journal: Genome Res
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Volume: 14
Issue: 10B
Pages: 2121-7
Publication
First Author: Church DM
Year: 2009
Journal: PLoS Biol
Title: Lineage-specific biology revealed by a finished genome assembly of the mouse.
Volume: 7
Issue: 5
Pages: e1000112